<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="34376" end="34381" sStart="34309" offset="67" sid="r7.1.use.v.0379" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="The present studies show that reduction of BRCA1 levels, using an antisense retroviral vector in the estrogen dependent BG-1 ovarian carcinoma cell line, may aid in confirmation of the hypothesis that BRCA1 functions as a tumor suppressor gene by playing a pivotal role in the balance between cell death and cell proliferation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr45.anc" start="20838" end="20849" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="Whole cell lysate (50 ?g) was loaded onto a 6% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel, &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose, and hybridized with an anti-BRCA1 (Ab-1; Oncogene Research, Cambridge, MA, USA) antibody as previously described [ 10]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="10269" end="10277" sStart="null" offset="122" sid="r8.suggest.v.0321" wn="" wnkey="null" annotator="veweser" text="The response of BRCA1 mRNA and protein levels to mitogens and hormones in vitro suggests that BRCA1 may play a role in regulation of cell growth or maintenance [ 21]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="31162" end="31169" sStart="null" offset="11" sid="r8.suggest.v.0113" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="These data suggest a correlation between the loss of BRCA1 protein and an increased survival/growth advantage in anchorage-independent conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="11084" end="11091" sStart="null" offset="27" sid="r8.suggest.v.0455" wn="3" wnkey="suggest%2:32:02::" annotator="brubin" text="The present data suggest that diminished levels of BRCA1 not only accelerate proliferation in the BG-1 ovarian carcinoma cell line, but also appear to promote tumorigenesis." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="11982" end="11988" sStart="null" offset="117" sid="r11.strong.j.0281" wn="2" wnkey="strong%5:00:00:intense:00" annotator="anfahmy" text="Initial analyses [ 22] suggested that women with germline mutations in the BRCA1 gene and a strong family history of breast or ovarian cancer have 85 and 44% lifetime risks of developing breast and ovarian cancer, respectively." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr45.anc" start="35448" end="35452" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="cgozo" text="All BRCA1 antisense subclones were able to proliferate as well as exhibit a decreased death &lt;b&gt;rate&lt;/b&gt; in estrogen-deprived media, whereas parental and control subclones failed to grow." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr45.anc" start="35448" end="35452" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="All BRCA1 antisense subclones were able to proliferate as well as exhibit a decreased death &lt;b&gt;rate&lt;/b&gt; in estrogen-deprived media, whereas parental and control subclones failed to grow." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr45.anc" start="14218" end="14223" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="Studies of BRCA1 expression patterns in mouse tissue reveal that BRCA1 is most highly expressed in tissues undergoing &lt;b&gt;rapid&lt;/b&gt; proliferation and differentiation, and that expression in vivo is also hormone responsive." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr45.anc" start="14218" end="14223" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" annotator="carichter" text="Studies of BRCA1 expression patterns in mouse tissue reveal that BRCA1 is most highly expressed in tissues undergoing &lt;b&gt;rapid&lt;/b&gt; proliferation and differentiation, and that expression in vivo is also hormone responsive." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="36130" end="36136" sStart="null" offset="32" sid="r8.number.n.0905" wn="1" wnkey="number%1:07:00::" annotator="veweser" text="The AS-4 clone formed a greater number of and larger tumors than NEO in the absence of estrogen, and in general formed tumors faster in the presence of estrogen." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="27528" end="27534" sStart="null" offset="225" sid="r8.number.n.0561" wn="1" wnkey="number%1:07:00::" annotator="veweser" text="During the first 5 days, both groups continued to proliferate in the absence of estrogen, but the BRCA1 antisense group continued to grow for the next 10 days, whereas control cells decreased in number (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="27930" end="27936" sStart="null" offset="103" sid="r8.number.n.0604" wn="1" wnkey="number%1:07:00::" annotator="cgozo" text="Figure 2bshows BG-1 parental and NEO clones exhibited up to a 37% decrease in cell number during a 3-day period of estrogen withdrawal, whereas antisense BRCA1 clones showed as much as a twofold increase in cell number during the same time period." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="42350" end="42356" sStart="null" offset="49" sid="r9.normal.j.0337" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="According to this model, cells without normal BRCA1 activity may accumulate genetic alterations as a result of failure to arrest and repair DNA damage or self-destruct, thereby leading to genomic instability and neoplastic progression." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="27646" end="27652" sStart="null" offset="90" sid="r9.level.n.0453" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="In order to avoid the problem of a mixed population of cells expressing various levels of BRCA1, subclones were isolated from infected populations of BRCA1 antisense infected BG-1 cells and control LXSN infected BG-1 cells (NEO)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="10969" end="10975" sStart="null" offset="10" sid="r9.level.n.0301" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="Low BRCA1 levels found in sporadic cancers may be an important factor in tumorigenesis." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="16551" end="16557" sStart="null" offset="204" sid="r9.level.n.0173" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="In addition, significant reduction in BRCA1 protein level correlates with enhanced estrogen proliferation when compared with cells that express moderate to wild-type BRCA1 levels, grown under optimal growth conditions both in vitro and in vivo ." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="5561" end="5567" sStart="null" offset="80" sid="r9.level.n.0615" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="Antisense technology was effective in decreasing both RNA and protein levels of BRCA1 in the BG-1 human ovarian adenocarcinoma cells." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="8184" end="8190" sStart="null" offset="22" sid="r9.level.n.0488" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="BRCA1 RNA and protein levels were successfully reduced in populations and isolated clones of antisense infected BG-1 cells." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="9425" end="9431" sStart="null" offset="6" sid="r9.level.n.0602" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="BRCA1 levels appear to affect the ability of cells to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="41058" end="41064" sStart="null" offset="50" sid="r9.level.n.0218" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="We found that clones with even moderately reduced levels of BRCA1 protein appeared to be relatively resistant to death due to estrogen deprivation." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="42772" end="42776" sStart="null" offset="184" sid="r10.high.j.0820" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="It may not be coincidental that BRCA1 -mutant breast cancers are preferentially linked to a 'specific' histopathologic pattern that includes a high S-phase fraction of cells, aneuploidy, and hormone receptor-negative status [ 45]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="40361" end="40369" sStart="null" offset="108" sid="r11.function.n.0671" wn="2" wnkey="function%1:07:00::" annotator="anfahmy" text="This is especially important during early embryonic development as well as in the development and function of adult tissues such as the gonadal cells (ie ovarian and testes) [ 41, 48]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="13134" end="13142" sStart="null" offset="56" sid="r11.function.n.0249" wn="2" wnkey="function%1:07:00::" annotator="adelpriore" text="Such alterations cannot be identified until the function and regulation of BRCA1 are better understood." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="28439" end="28443" sStart="null" offset="16" sid="r9.fold.v.0801" wn="2147483645" wnkey="null" annotator="veweser" text="There were 5-10-fold more dead cells present in the media of control cells (BG-1 parental and NEO clone) then in the BRCA1 antisense clone AS-4 (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="29197" end="29201" sStart="null" offset="78" sid="r9.fold.v.0157" wn="2147483645" wnkey="null" annotator="veweser" text="Antisense BRCA1 clones 1, 3 and 4 showed a 10-fold to 16-fold increase in cell number between days 5 and 8 after estrogen treatment compared with only a threefold to fivefold increase of cell number in NEO clones and BG-1 parental cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="5872" end="5879" sStart="null" offset="237" sid="r10.control.n.0161" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="BRCA1 antisense-infected populations contained significantly less BRCA1 message than control LXSN-infected pools and selected clones contained varying reduced levels of BRCA1 protein compared with control clones (Figs 1aand 1b)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="25687" end="25694" sStart="null" offset="100" sid="r10.control.n.0700" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="BRCA1 antisense infected cells contained significantly less BRCA1 message than control LXSN infected cells, whether cultured in the presence or absence of estrogen (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="36437" end="36445" sStart="null" offset="147" sid="r10.control.n.0306" wn="4" wnkey="control%1:09:02::" annotator="anfahmy" text="The main conclusion from these studies is that BG-1 clones with reduced levels of BRCA1 protein have a survival advantage over controls in the absence of estrogen both in vitro and in vivo." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="30033" end="30039" sStart="null" offset="34" sid="r10.common.j.0636" wn="2" wnkey="common%3:00:01::" annotator="brubin" text="Anchorage independent growth is a common property of many transformed cells." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="34900" end="34908" sStart="null" offset="34" sid="r9.appear.v.0684" wn="1" wnkey="appear%2:39:00::" annotator="brubin" text="Decreased BRCA1 levels appeared to affect the ability of BG-1 cells to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="43945" end="43951" sStart="null" offset="166" sid="r9.appear.v.0208" wn="1" wnkey="appear%2:39:00::" annotator="brubin" text="The present data suggest that diminished levels of BRCA1 not only accelerate proliferation in the BG-1 ovarian carcinoma cell line, but appear to alter tumorigenesis." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="36184" end="36191" sStart="null" offset="86" sid="r11.absence.n.0901" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="The AS-4 clone formed a greater number of and larger tumors than NEO in the absence of estrogen, and in general formed tumors faster in the presence of estrogen." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="9511" end="9518" sStart="null" offset="92" sid="r11.absence.n.0859" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="BRCA1 levels appear to affect the ability of cells to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="33709" end="33716" sStart="null" offset="80" sid="r11.absence.n.0355" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="Neither AS-4 nor NEO cells formed progressively growing tumors in the absence of estrogen, however." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="21543" end="21550" sStart="null" offset="451" sid="r11.absence.n.0307" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="G418-resistant colonies from BRCA1 antisense infected BG-1 cells and control vector LXSN-infected BG-1 cells were pooled, pretreated for 5 days in phenol red-free, DMEM/F-12 medium (Gibco/Life Technologies) supplemented with 10% charcoal/dextran treated serum (Hyclone, Logan, UT, USA), then plated at 2.5 ? 10 6cells per 100mm dish in triplicate for growth curve analysis in the absence or presence of estrogen (10 -8mol/l; 17?-Estradiol; 1,3,5 (10) - Estratriene 3, 17?-diol; Sigma, St Louis, MO, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="3509" end="3516" sStart="null" offset="258" sid="r11.absence.n.0893" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="After 2 weeks of selection in 800 ?g/ml of geneticin-G418 (Gibco/Life Technologies, Gaithersburg, MD, USA), BG-1 G418-resistant colonies were pooled, or individually isolated, and assayed for growth in the presence or absence of supplemented estrogen." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="44130" end="44137" sStart="null" offset="154" sid="r11.absence.n.0050" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="The exact mechanism may be unknown, but decreased BRCA1 levels appear to affect the ability to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="34996" end="35003" sStart="null" offset="130" sid="r11.absence.n.0813" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="Decreased BRCA1 levels appeared to affect the ability of BG-1 cells to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="26629" end="26636" sStart="null" offset="105" sid="r11.absence.n.0666" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="Pooled populations of antisense BRCA1 BG-1 colonies were examined for growth in the absence or presence of supplemented estrogen." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="19140" end="19147" sStart="null" offset="256" sid="r11.absence.n.0174" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="After 2 weeks of selection in 800 ?g/ml of geneticin-G418 (Gibco/Life Technologies, Gaithersburg, MD, USA), BG-1 G418-resistant colonies were pooled or individually isolated and assayed for growth in the presence or absence of supplemented estrogen." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="32137" end="32144" sStart="null" offset="7" sid="r11.absence.n.0108" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="In the absence of estrogen, a significant difference was detected in tumorigenic growth between AS-4 and NEO cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="44130" end="44137" sStart="null" offset="154" sid="r11.absence.n.0050" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="The exact mechanism may be unknown, but decreased BRCA1 levels appear to affect the ability to arrest growth or die in the absence of estrogenic growth-inducing conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="6662" end="6666" sStart="null" offset="43" sid="r11.able.j.0799" wn="1" wnkey="able%3:00:00::" annotator="vebatchelder" text="All of the antisense clones were able to form colonies in soft agar (2-23 colonies per 10 4cells plated; data not shown), whereas control clones were deficient in their ability to form colonies (0-0." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr45.anc" start="30926" end="30930" sStart="null" offset="62" sid="r11.able.j.0947" wn="1" wnkey="able%3:00:00::" annotator="anfahmy" text="In the presence of estrogen, both NEO and AS-4 were able to form colonies; however, there was a significant difference ( P &lt;0." />
  </sentences>
</list>